News - UF Innovate

1000X More Efficient Neural Networks: Building an Artificial Brain With 86 Billion Physical (but Not Biological) Neurons

What if in our attempt to build artificial intelligence we don’t simulate neurons in code and mimic neural networks in Python, but instead build actual physical neurons connected by physical synapses in ways very similar to our own biological brains? That’s precisely what UF startup Rain Neuromorphics, is trying to do: build a non-biological yet very human-style artificial brain.

Rhes Protein Key in Spread of Huntington’s Disease In the Brain

Pathogenic proteins help spread many neurodegenerative diseases. How they move between brain cells is often shrouded in mystery. But scientists at Scripps Research’s Florida campus have found that nanotube tunnels that act like roadways capable of transporting cargo between cells can transmit a toxic protein linked to Huntington’s disease from neuron to neuron.

Exactech Announces New Patent, Strengthening Company’s Position in Joint Replacement Soft Tissue Management

UF startup Exactech, announces new patent or the Newton™ Knee, a dynamic platform of cutting-edge technology used with forward-thinking implants that are designed to provide optimal balance in a reproducible way.

Oragenics Initiates a Pivotal IND-Enabling Toxicology Study on Its Intranasal COVID-19 Vaccine Candidate, NT-CoV2-1

Oragenics, Inc., announced the initiation of a Good Laboratory Practice (GLP) toxicology study to evaluate the safety profile and immunogenicity of its NT-CoV2-1 vaccine

Scientists and Farmers See Ways To Make AI Useful to Agriculture

In a groundbreaking, first-of-its kind event, university scientists, engineers, producers, government agencies and industry officials from throughout the South met at Auburn University to brainstorm ways to use artificial intelligence to help farmers.

New COVID Test Can Quickly Detect Variants

University of Florida researchers have invented a test that can determine within 10-15 minutes whether patients test positive for COVID and, if so, which of the five known variants of concern they have.

Dialectic Therapeutics Announces DT2216 Has Received Orphan Drug Designation From the FDA for the Treatment of T-Cell Lymphoma

UF startup Dialectic Therapeutics, Inc. (Dialectic®), announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to DT2216 for the treatment of T-cell lymphoma.

UF Announces Artificial Intelligence Academic Initiative Center

In its latest step to promote artificial intelligence (AI) and data science and integrate AI across the curriculum, the University of Florida announced that it will create an Artificial Intelligence Academic Initiative Center.

Oragenics Engages KBI Biopharma to Support Development of Intranasal COVID-19 Vaccine Candidate NT-CoV2-1

Oragenics, Inc. announced it has entered into an agreement with KBI Biopharma, Inc. for the process transfer, process optimization, and cGMP manufacturing of Oragenics’s intranasal vaccine candidate NT-CoV2-1, which is expressed in a proprietary CHO cell line.

Researcher Gains New Insight Into How Cells Sense, Address Protein-Building Malfunctions

The process of how cells sense a glitch and begin repairs so the machinery can return to its protein-building job — as well as how cells dispose of the aberrant proteins produced by the glitch — has become clearer due to the work of Scripps Florida professor Claudio Joazeiro, Ph.D., and his collaborators. The findings were published in the journal Nature on March 9.

UF News